Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04969081 · ClinicalTrials.gov registry record · NA
Impact of Work Activity on SUD Outcomes
A NA study of Substance-Related Disorders, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT04969081: Active NA study of Substance-Related Disorders, sponsored by VA Office of Research and Development.
NCT04969081 is a NA study of Substance-Related Disorders that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 103 participants, below the 1,519-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04969081, a NA study of Substance-Related Disorders, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
To date, there are no studies of the therapeutic effects of varied work-focused programs in Veterans undergoing outpatient substance use disorder (SUD) treatment. The investigators propose a randomized clinical trial to test the effects of work-focused programs on improving sobriety and other clinical outcomes in Veterans early in the course of recovery from SUD. Veterans will be randomized to either receive or not receive referral for work-focused therapeutic programs. Primary aim is to examine effects of work-focused programs on sobriety outcomes, namely sobriety and global functioning. Secondary aim is to examine effects of work-focused programs on psychiatric symptoms, self esteem/efficacy, and quality of life.
Primary Outcome
percent days abstinent during 3-month active phase
Conditions Studied
Interventions
- BEHAVIORAL referral to work focused program
- OTHER treatment as usual
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What the registry record for NCT04969081 still lists
NCT04969081 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,519-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which referral to work focused program is the first listed.
NCT04969081 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04969081 about?
NCT04969081 is a clinical study titled "Impact of Work Activity on SUD Outcomes". To date, there are no studies of the therapeutic effects of varied work-focused programs in Veterans undergoing outpatient substance use disorder (SUD) treatment. The investigators propose a randomized clinical trial to test the effects of work-focused programs on improving sobriety and other clinic...
What is the current status of trial NCT04969081?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2022-01-03. Estimated completion is 2028-12-31.
What conditions does trial NCT04969081 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT04969081?
The interventions under investigation include: referral to work focused program (BEHAVIORAL), treatment as usual (OTHER).
Who is sponsoring clinical trial NCT04969081?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04969081 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04969081's enrollment target sits among peer trials
103 34th of 58 higher than 25 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI